These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16126985)

  • 1. Cellular and molecular mechanisms of regulation of autoantibody production in lupus.
    Hahn BH; Ebling F; Singh RR; Singh RP; Karpouzas G; La Cava A
    Ann N Y Acad Sci; 2005 Jun; 1051():433-41. PubMed ID: 16126985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of immune regulation in systemic lupus erythematosus.
    La Cava A; Fang CJ; Singh RP; Ebling F; Hahn BH
    Autoimmun Rev; 2005 Nov; 4(8):515-9. PubMed ID: 16214088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
    Shivakumar S; Tsokos GC; Datta SK
    J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
    Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
    J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
    Singh RR; Ebling FM; Sercarz EE; Hahn BH
    J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
    Singh RP; Hahn BH; Bischoff DS
    Front Immunol; 2021; 12():662901. PubMed ID: 34093553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells.
    Datta SK
    Lupus; 1998; 7(9):591-6. PubMed ID: 9884095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self Ig peptides that help anti-DNA antibody production: importance of charged residues.
    Hahn BH; Singh RR; Ebling FM
    Lupus; 1998; 7(5):307-13. PubMed ID: 9696134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8
    Singh RP; Hahn BH; Bischoff DS
    Front Immunol; 2021; 12():718359. PubMed ID: 34867947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action.
    Sharabi A; Azulai H; Sthoeger ZM; Mozes E
    Immunology; 2007 Jun; 121(2):248-57. PubMed ID: 17346282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
    Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
    Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
    Kang HK; Michaels MA; Berner BR; Datta SK
    J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
    Levite M; Zinger H; Mozes E; Reisner Y
    Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.
    Desai-Mehta A; Mao C; Rajagopalan S; Robinson T; Datta SK
    J Clin Invest; 1995 Feb; 95(2):531-41. PubMed ID: 7860735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.